Import and sourcing
APIs, excipients and finished products from manufacturers we already work with, brought into Iran with the certificates and stability data the authority expects.
Medicines and ingredients for Iran, sourced and registered by one team.
Hanpars imports active ingredients, finished medicines, excipients and nutrition ingredients, and registers them with the IFDA. Based in Tehran, with suppliers in Türkiye, China, India and Europe.
Three things we do, usually together.
A supply agreement is only useful once the product is approved and on the shelf, so sourcing, registration and project coordination sit with the same people.
Regulatory affairs
Strategy before the first study. Evidence built into the dossier. Approval secured. Authorisation maintained through every change.
Development partnerships
For finished dosage-form projects we coordinate development and manufacturing partners, with responsibilities written down at the start. We run the project; partners run the plant.
The Finished Dosage Form Portfolio
46Urgent medicines registered with the IFDA
30available in Iran
16launching
Contrast media, anaesthetics, antibiotics, hormones, vaccines and biologics from manufacturers holding international GMP certification, distributed nationally through Iran’s main pharmaceutical distributors. Hanpars is a contracted supplier to the national Strategic Medicine Reserve.
شرکت هانیا پرسان دارو
A trading company in Tehran that holds its own licences.
Hanpars is the marketing authorisation holder for the medicines it imports: the dossier, the IRC licence and pharmacovigilance are handled in-house. We source, register and coordinate; manufacturers manufacture, and the authority decides. Saying precisely who does what is how we keep projects moving.
- 3rd floor, No. 326, Zafar Street, Africa Boulevard, Tehran
- Office hours 09:00–17:00
- +98 21 8888 3325
How a request proceeds
A product name and a destination are enough to start.
Tell us what you need
The product, the strength or grade, the quantity and where it is going.
We put it in context
Who can supply it, what the market will require, and what is realistic for timing.
We agree the scope
Who does what, in writing, with one contact at Hanpars accountable for it.
In the news today
All of today's stories
GSK's double FDA win, Roche's $15B deal and the rise of point-of-care marketing
This week on "The Top Line," we cover GSK's pair of FDA approvals, Roche's $15 billion ADC deal and the rise of point-of-care pharma marketing.
Read at fiercepharma.com
FDA Approves Subcutaneous Induction for Skyrizi in Crohn's Disease
FDA approved an at-home induction option for risankizumab-rzaa in adults with moderate-to-severe Crohn's disease, based on the phase 3 AFFIRM trial.
Read at pharmexec.com
ProBio Successfully Completes NMPA Pre-Approval Inspection for Biologics Manufacturing Facility in Nanjing, China
ProBio Successfully Completes NMPA Pre-Approval Inspection for Biologics Manufacturing Facility in Nanjing, China PR Newswire
Read at prnewswire.comFrequently asked questions
What does Haniya Parsan Darou import?
Haniya Parsan Darou supplies and imports hospital and specialty finished medicines, active pharmaceutical ingredients (APIs), pharmaceutical excipients, and raw materials for pharmaceutical and food supplements for the Iranian market.
What is urgent (emergency) medicine import, and what is Hanpars' role?
Urgent import is the supply of medicines that are imported with the approval of the Iran Food and Drug Administration (IFDA) to relieve a shortage or meet an immediate treatment need. Haniya Parsan Darou holds an IFDA import licence and handles the sourcing, registration and nationwide distribution of these medicines through established pharmaceutical distributors.
Does Haniya Parsan Darou register medicines with the IFDA?
Yes. The company's regulatory team prepares the dossier, obtains the IRC code, and handles pharmacovigilance, variations and licence renewals, both for its own imported products and for foreign manufacturers.
Where are the active pharmaceutical ingredients (APIs) sourced from?
Active ingredients and excipients are sourced from manufacturers with recognised GMP certification in China, India, Türkiye and Europe, together with the required documentation such as the CoA, DMF or CEP.
How do I send a purchase or quotation request for medicines or raw materials?
Send the product or active-ingredient name, the grade or strength, the quantity and the destination market through the website's contact form, or call +98 21 8888 3325. For regulatory matters, email RA@hanpars.com.
Tell us the product and the market. We will tell you the next step.
Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.